<?xml version="1.0" encoding="UTF-8"?>
<p>By 2019, over 2.4 million Egyptians had been treated, and the country is on track to achieve WHO elimination targets in spite of its high hepatitis C prevalence (Figure 
 <xref rid="liv14222-fig-0006" ref-type="fig">6</xref>C).
 <xref rid="liv14222-bib-0078" ref-type="ref">78</xref>, 
 <xref rid="liv14222-bib-0079" ref-type="ref">79</xref> Egypt's response was facilitated by strong political will and government advocacy, effective price negotiations, removal of patent barriers on DAAs and ability to produce DAAs locally.
 <xref rid="liv14222-bib-0066" ref-type="ref">66</xref>, 
 <xref rid="liv14222-bib-0080" ref-type="ref">80</xref>
</p>
